These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29170979)

  • 41. Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis.
    Balmuri N; Soulsby WD; Cooley V; Gerber L; Lawson E; Goodman S; Onel K; Mehta B;
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):122. PubMed ID: 34391453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.
    Al-Mayouf SM; AlMutiari N; Muzaffer M; Shehata R; Al-Wahadneh A; Abdwani R; Al-Abrawi S; Abu-Shukair M; El-Habahbeh Z; Alsonbul A
    Rheumatol Int; 2017 Sep; 37(9):1513-1517. PubMed ID: 28685324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study.
    Sanner H; Kirkhus E; Merckoll E; Tollisen A; Røisland M; Lie BA; Taraldsrud E; Gran JT; Flatø B
    Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1103-11. PubMed ID: 20506141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective validation of the Juvenile Spondyloarthritis Disease Activity Index in children with enthesitis-related arthritis.
    Zanwar A; Phatak S; Aggarwal A
    Rheumatology (Oxford); 2018 Dec; 57(12):2167-2171. PubMed ID: 30107576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study.
    Arnstad ED; Rypdal V; Peltoniemi S; Herlin T; Berntson L; Fasth A; Nielsen S; Glerup M; Ekelund M; Zak M; Aalto K; Nordal E; Romundstad PR; Rygg M;
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):961-969. PubMed ID: 30055093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The arthritis of inflammatory childhood myositis syndromes.
    Tse S; Lubelsky S; Gordon M; Al Mayouf SM; Babyn PS; Laxer RM; Silverman ED; Schneider R; Feldman BM
    J Rheumatol; 2001 Jan; 28(1):192-7. PubMed ID: 11196524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duration of illness is an important variable for untreated children with juvenile dermatomyositis.
    Pachman LM; Abbott K; Sinacore JM; Amoruso L; Dyer A; Lipton R; Ilowite N; Hom C; Cawkwell G; White A; Rivas-Chacon R; Kimura Y; Ray L; Ramsey-Goldman R
    J Pediatr; 2006 Feb; 148(2):247-53. PubMed ID: 16492437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcome in patients with juvenile dermatomyositis: A case series.
    Chevalier G; Fakih O; Lhose A; Ballot-Schmit C; Prati C; Puzenat E; Aubin F
    Arch Pediatr; 2021 Aug; 28(6):475-479. PubMed ID: 34034928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
    Wu EY; Li SC; Torok KS; Virkud YV; Fuhlbrigge RC; Rabinovich CE;
    ACR Open Rheumatol; 2019 Apr; 1(2):119-124. PubMed ID: 31777788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study.
    Apaz MT; Saad-Magalhães C; Pistorio A; Ravelli A; de Oliveira Sato J; Marcantoni MB; Meiorin S; Filocamo G; Pilkington C; Maillard S; Al-Mayouf S; Prahalad S; Fasth A; Joos R; Schikler K; Mozolova D; Landgraf JM; Martini A; Ruperto N;
    Arthritis Rheum; 2009 Apr; 61(4):509-17. PubMed ID: 19333974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
    Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S
    Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.
    Sanner H; Gran JT; Sjaastad I; Flatø B
    Rheumatology (Oxford); 2009 Dec; 48(12):1541-7. PubMed ID: 19776224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CARRA: The Childhood Arthritis and Rheumatology Research Alliance.
    Fuhlbrigge RC; Schanberg LE; Kimura Y
    Rheum Dis Clin North Am; 2021 Nov; 47(4):531-543. PubMed ID: 34635290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
    Mamyrova G; Kishi T; Targoff IN; Ehrlich A; Curiel RV; Rider LG;
    Rheumatology (Oxford); 2018 Nov; 57(11):1956-1963. PubMed ID: 30016492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Access to Care and Diagnostic Delays in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
    Neely J; Shalen J; Sturrock H; Kim S;
    ACR Open Rheumatol; 2021 May; 3(5):349-354. PubMed ID: 33932146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis.
    Rosina S; Consolaro A; van Dijkhuizen P; Pistorio A; Varnier GC; Bovis F; Nistala K; Maillard S; Civino A; Tsitsami E; de Inocencio J; Jelusic M; Vojinovic J; Espada G; Makay B; Katsicas MM; Pratsidou-Gertsi P; Lazarevic D; Rao AP; Pires Marafon D; Martini A; Pilkington C; Ruperto N; Ravelli A
    Rheumatology (Oxford); 2019 Jul; 58(7):1196-1205. PubMed ID: 30690571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study.
    McErlane F; Foster HE; Carrasco R; Baildam EM; Chieng SE; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL
    Rheumatology (Oxford); 2016 Jul; 55(7):1225-34. PubMed ID: 27016664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative muscle ultrasonography in the follow-up of juvenile dermatomyositis.
    Habers GE; Van Brussel M; Bhansing KJ; Hoppenreijs EP; Janssen AJ; Van Royen-Kerkhof A; Pillen S
    Muscle Nerve; 2015 Oct; 52(4):540-6. PubMed ID: 25557638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
    Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
    Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.
    Maillard SM; Jones R; Owens C; Pilkington C; Woo P; Wedderburn LR; Murray KJ
    Rheumatology (Oxford); 2004 May; 43(5):603-8. PubMed ID: 14983103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.